Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical improvement | clinical worsening | deaths | PCR-negative conversion | |||
| anticoagulant | - | - | OBS 1.03 [0.63; 1.67], 1 study, I2=0% inconclusive result | - | ||
| colchicine | - | 0.11 [0.01; 1.08], 1 RCT, I2=0% inconclusive result | - | - | ||
| face mask | 0 | - | - | - | - | |
| febuxostat | 0 | - | - | - | - | |
| hydrogen-oxygen nebulizer | 0 | - | - | - | - | |
| hyperbaric oxygen | 0 | - | - | - | - | |
| nintedanib | 0 | - | - | - | - | |
| pulmonary rehabilitation | 0 | - | - | - | - | |
| thalidomide | 0 | - | - | - | - | |
| vitamin C | 0 | - | - | - | - | |
-
About us
-
Contact us
-
Method
Made with in Lyon
-
Credits
-
Privacy policy
-
